MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$107,322,000K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-12-31
2024-12-31
Revenues
0
131,161
Research and development expense
0
227,702
Selling, general and administrative
0
115,450
Cost of product revenue
0
5,279
Total cost and operating expenses
0
348,431
Loss from operations
0
-217,270
Other income (expense), net
0
1,217
Investment income, net
0
19,701
Gain from sale of priority review voucher
0
108,000
Total non-operating income, net
0
128,918
Loss before income taxes
0
88,352
Income tax expense
0
7,144
Net loss
-107,322,000
-95,496
Basic EPS
-
-1.02
Diluted EPS
-
-1.02
Basic Average Shares
-
93,234,195
Diluted Average Shares
-
93,234,195
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$107,322,000K
(-112283.76%↓ Y/Y)
something is missing
-$107,322,000K
Buy us a coffee
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)